Epstein-Barr virus infection: the micro and macro worlds.

EBV-associated diseases Epstein‒Barr virus Immune escape Immune response

Journal

Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645

Informations de publication

Date de publication:
02 10 2023
Historique:
received: 19 07 2023
accepted: 19 09 2023
medline: 4 10 2023
pubmed: 3 10 2023
entrez: 2 10 2023
Statut: epublish

Résumé

Epstein‒Barr virus (EBV) is a DNA virus that belongs to the human B lymphotropic herpesvirus family and is highly prevalent in the human population. Once infected, a host can experience latent infection because EBV evades the immune system, leading to hosts harboring the virus for their lifetime. EBV is associated with many diseases and causes significant challenges to human health. This review first offers a description of the natural history of EBV infection, clarifies the interaction between EBV and the immune system, and finally focuses on several major types of diseases caused by EBV infection.

Identifiants

pubmed: 37784180
doi: 10.1186/s12985-023-02187-9
pii: 10.1186/s12985-023-02187-9
pmc: PMC10546641
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

PLoS Pathog. 2014 May 29;10(5):e1004170
pubmed: 24874410
Trends Microbiol. 2020 Feb;28(2):150-162
pubmed: 31624007
Curr Opin Virol. 2013 Jun;3(3):227-32
pubmed: 23683686
Am J Pathol. 1987 Oct;129(1):86-91
pubmed: 2821817
Semin Cancer Biol. 2014 Jun;26:52-9
pubmed: 24602823
J Immunol. 2010 Dec 1;185(11):6439-47
pubmed: 20980631
J Virol. 2008 Aug;82(15):7456-66
pubmed: 18480445
Oncogene. 2009 Nov 5;28(44):3903-14
pubmed: 19718044
J Virol. 2015 Feb;89(4):2301-12
pubmed: 25505080
Semin Cancer Biol. 2014 Jun;26:60-8
pubmed: 24457012
Cell. 2022 Sep 29;185(20):3652-3670
pubmed: 36113467
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11583-8
pubmed: 14504389
J Virol. 2009 Jan;83(2):1140-6
pubmed: 18987133
Virology. 2010 Jun 20;402(1):121-8
pubmed: 20381110
Cancer Res. 2009 Apr 1;69(7):2766-74
pubmed: 19339266
Int J Cancer. 1990 Nov 15;46(5):801-4
pubmed: 2172169
Mol Carcinog. 2005 Oct;44(2):92-101
pubmed: 16086371
Cell. 2004 Aug 20;118(4):431-8
pubmed: 15315756
Cancer Res. 2016 Apr 15;76(8):2137-52
pubmed: 26951929
Molecules. 2019 Mar 12;24(5):
pubmed: 30871092
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
J Virol. 2007 Feb;81(4):1554-62
pubmed: 17151127
mBio. 2019 Jan 15;10(1):
pubmed: 30647153
Cancer Lett. 2015 May 28;361(1):67-74
pubmed: 25721089
PLoS One. 2010 Jul 30;5(7):e11908
pubmed: 20689596
J Virol. 1989 Jul;63(7):3109-16
pubmed: 2542618
Gastric Cancer. 2020 Nov;23(6):951-960
pubmed: 32514646
J Virol. 2005 Apr;79(8):4896-907
pubmed: 15795275
J Immunol. 1999 Nov 15;163(10):5735-40
pubmed: 10553106
Cell Rep. 2013 Feb 21;3(2):371-85
pubmed: 23416052
Oral Oncol. 2012 Aug;48(8):703-8
pubmed: 22366442
Virol J. 2009 Mar 05;6:29
pubmed: 19265546
Nat Commun. 2019 Aug 29;10(1):3891
pubmed: 31467275
Front Microbiol. 2021 Jun 22;12:701611
pubmed: 34239514
Autophagy. 2021 Jun;17(6):1296-1315
pubmed: 32401605
Trends Immunol. 2014 Apr;35(4):159-69
pubmed: 24589417
Cell. 1988 Nov 4;55(3):427-33
pubmed: 2846181
Immunity. 2000 Oct;13(4):497-506
pubmed: 11070168
Nat Commun. 2015 Feb 11;6:6240
pubmed: 25670642
Open Forum Infect Dis. 2022 Nov 25;9(12):ofac635
pubmed: 36519117
Lancet. 1964 Mar 28;1(7335):702-3
pubmed: 14107961
Nat Commun. 2017 Oct 16;8(1):945
pubmed: 29038422
Cell Rep. 2019 Jul 9;28(2):449-459.e5
pubmed: 31291580
J Virol. 1992 Jun;66(6):3409-14
pubmed: 1316456
J Virol. 2014 Nov;88(21):12193-201
pubmed: 25142593
PLoS Pathog. 2009 Jun;5(6):e1000492
pubmed: 19557159
Cell Host Microbe. 2016 Feb 10;19(2):150-8
pubmed: 26867174
J Clin Invest. 2001 Oct;108(8):1097-104
pubmed: 11602615
J Exp Med. 2005 Feb 7;201(3):349-60
pubmed: 15684323
J Innate Immun. 2017;9(6):574-586
pubmed: 28877527
J Virol. 2015 May;89(10):5581-91
pubmed: 25740983
J Immunol. 2008 Feb 1;180(3):1643-54
pubmed: 18209060
Nature. 2013 Jun 20;498(7454):380-4
pubmed: 23722158
J Mol Biol. 2022 Mar 30;434(6):167214
pubmed: 34437888
J Virol. 2014 Jan;88(2):1389-93
pubmed: 24227849
Int J Cancer. 2006 Apr 15;118(8):1853-61
pubmed: 16385563
J Virol. 1990 Sep;64(9):4084-92
pubmed: 2166806
Clin Cancer Res. 2004 Feb 1;10(3):803-21
pubmed: 14871955
Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1276-85
pubmed: 17001105
Nat Rev Immunol. 2009 Aug;9(8):535-42
pubmed: 19556980
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):437-42
pubmed: 11752411
Cancer Med. 2015 Dec;4(12):1908-22
pubmed: 26377256
J Virol. 2007 Aug;81(15):7825-32
pubmed: 17459936
Blood. 2012 Jan 19;119(3):673-86
pubmed: 22096243
Virol J. 2017 Nov 13;14(1):221
pubmed: 29132393
J Virol. 2006 Dec;80(23):11638-50
pubmed: 16987978
Dev Biol Stand. 1995;84:171-7
pubmed: 7796951
Blood. 2011 Jun 2;117(22):5835-49
pubmed: 21454450
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
PLoS Pathog. 2014 Feb 20;10(2):e1003960
pubmed: 24586164
Oncogene. 2009 Apr 9;28(14):1725-35
pubmed: 19234486
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11157-62
pubmed: 25012295
Cancer Metastasis Rev. 2017 Sep;36(3):435-447
pubmed: 28819752
Nucleic Acids Res. 2014 Jan;42(1):249-63
pubmed: 24097438
Nature. 2012 Oct 4;490(7418):116-20
pubmed: 22885699
PLoS Pathog. 2009 Jan;5(1):e1000255
pubmed: 19119421
J Trop Pediatr. 1990 Jun;36(3):114-20
pubmed: 2163460
Immunity. 2019 May 21;50(5):1305-1316.e6
pubmed: 30979688
Clin Dev Immunol. 2013;2013:535738
pubmed: 24062777
Vaccines (Basel). 2020 Apr 06;8(2):
pubmed: 32268575
J Virol. 1981 Apr;38(1):305-16
pubmed: 6264105
Cancers (Basel). 2018 Jun 13;10(6):
pubmed: 29899236
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9194-9
pubmed: 8799177
Cancer Res. 2002 Dec 1;62(23):6952-8
pubmed: 12460912
J Virol. 2003 Oct;77(19):10179-85
pubmed: 12970403
Blood. 2018 Jun 28;131(26):2899-2905
pubmed: 29712633
Front Immunol. 2019 Sep 18;10:2193
pubmed: 31620125
mBio. 2021 Dec 21;12(6):e0224321
pubmed: 34781735
J Immunol. 2011 Feb 1;186(3):1694-702
pubmed: 21191071
Annu Rev Immunol. 2015;33:787-821
pubmed: 25706097
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8479-83
pubmed: 8397406
Rev Med Virol. 2014 May;24(3):142-53
pubmed: 24339346
J Immunol. 2010 Sep 15;185(6):3620-31
pubmed: 20713890
J Exp Med. 2009 Sep 28;206(10):2091-9
pubmed: 19720839
PLoS One. 2014 Jun 10;9(6):e99857
pubmed: 24914816
Eur J Immunol. 2013 Jan;43(1):147-58
pubmed: 22996354
Immunol Rev. 1997 Jun;157:217-22
pubmed: 9255632
J Gen Virol. 2010 Jan;91(Pt 1):42-50
pubmed: 19793909
Virol J. 2021 Nov 8;18(1):218
pubmed: 34749760
J Virol. 2012 Nov;86(22):12176-86
pubmed: 22933289
J Pathol. 2008 Sep;216(1):83-92
pubmed: 18566961
J Virol. 2009 Apr;83(8):3968-76
pubmed: 19193789
J Virol. 2009 Feb;83(4):1856-69
pubmed: 19052084
Blood. 2013 Oct 10;122(15):2600-8
pubmed: 23974196
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
J Immunol. 2011 Mar 15;186(6):3594-605
pubmed: 21296983
Rev Med Virol. 2005 Jan-Feb;15(1):3-15
pubmed: 15386591
Ann Rheum Dis. 2013 Sep 1;72(9):1559-68
pubmed: 23268369
Nat Immunol. 2018 Jan;19(1):53-62
pubmed: 29180807
Mod Pathol. 2017 Mar;30(3):427-439
pubmed: 27934877
Arthritis Rheum. 2010 Jun;62(6):1693-701
pubmed: 20178121
IARC Sci Publ (1971). 1978;(20):3-12
pubmed: 215516
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2467-72
pubmed: 22308454
Int J Cancer. 2005 Jun 20;115(3):368-76
pubmed: 15688379
Front Oncol. 2019 Mar 15;9:127
pubmed: 30931253
Semin Immunol. 2022 Mar;60:101652
pubmed: 36162228
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3621-6
pubmed: 9520415
N Engl J Med. 2000 Aug 17;343(7):481-92
pubmed: 10944566
J Gen Virol. 1996 Aug;77 ( Pt 8):1883-92
pubmed: 8760440
J Infect Dis. 2003 Feb 15;187(4):527-33
pubmed: 12599068
Hum Pathol. 2016 Sep;55:182-9
pubmed: 27260946
Arthritis Res Ther. 2016 Jun 03;18(1):127
pubmed: 27255888
Front Immunol. 2017 Dec 22;8:1867
pubmed: 29375552
Springer Semin Immunopathol. 1998;20(3-4):325-42
pubmed: 9870249
Blood. 2007 Nov 15;110(10):3715-21
pubmed: 17682125
Leukemia. 2021 Apr;35(4):968-981
pubmed: 33686198
Pathobiology. 2015;82(5):212-23
pubmed: 26337667
J Immunol. 2009 Feb 15;182(4):1799-809
pubmed: 19201831
Clin Microbiol Rev. 2011 Jan;24(1):193-209
pubmed: 21233512
Nat Rev Microbiol. 2021 Feb;19(2):110-121
pubmed: 33087881
Br J Haematol. 2014 Sep;166(6):875-90
pubmed: 25041527
Front Immunol. 2023 Jan 11;13:1079515
pubmed: 36713430
Virology. 1986 Oct 15;154(1):56-66
pubmed: 3019008
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3366-71
pubmed: 17360652
Cell. 1989 Feb 10;56(3):369-77
pubmed: 2464439
Front Microbiol. 2017 Sep 27;8:1853
pubmed: 29033912
Curr Top Microbiol Immunol. 2015;391:325-53
pubmed: 26428380
J Virol. 2010 Apr;84(7):3612-23
pubmed: 20089650
PLoS Pathog. 2023 Feb 21;19(2):e1011186
pubmed: 36802409
PLoS Pathog. 2009 Mar;5(3):e1000341
pubmed: 19283066
J Virol. 2005 Aug;79(15):10040-52
pubmed: 16014964
Auris Nasus Larynx. 2011 Apr;38(2):244-9
pubmed: 20817430
Insights Imaging. 2019 May 21;10(1):56
pubmed: 31115699
Rev Med Virol. 2014 Nov;24(6):365-78
pubmed: 24733560
J Infect Dis. 2005 Nov 1;192(9):1503-4
pubmed: 16206063

Auteurs

Wei Huang (W)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China.
Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China.

Lang Bai (L)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China. pangbailang@163.com.
Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China. pangbailang@163.com.

Hong Tang (H)

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, 610041, China. tanghong6198@wchscu.cn.
Division of Infectious Diseases, State Key Laboratory of Biotherapy and Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, China. tanghong6198@wchscu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH